Sjs Investment Consulting Inc. Alkermes Plc. Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q1 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 23 shares of ALKS stock, worth $722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$722
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
383Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$914 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$581 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$385 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$277 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$237 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.16B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...